Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.1% on Tuesday.
今天上午美國股票期貨小幅走低，納斯達克期貨週二下跌約0.1％。
Shares of Medifast, Inc. (NYSE:MED) fell sharply in today's pre-market trading after the company reported mixed first-quarter financial results.
Medifast, Inc.（紐約證券交易所代碼：MED）的股價在今天的盤前交易中大幅下跌，此前該公司公佈的第一季度財務業績喜憂參半。
Medifast posted adjusted earnings of 66 cents per share, missing market estimates of 78 cents per share. The company's quarterly sales came in at $174.739 million versus expectations of $168.900 million, according to data from Benzinga Pro.
Medifast公佈的調整後每股收益爲66美分，未達到市場預期的每股78美分。根據Benzinga Pro的數據，該公司的季度銷售額爲1.74739億美元，而預期的爲1.689億美元。
Medifast shares tumbled 15.6% to $29.95 in pre-market trading.
在盤前交易中，Medifast股價下跌15.6％，至29.95美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是一些在今天的盤前交易時段中錄得虧損的大型股票。
- Coursera, Inc. (NYSE:COUR) shares dipped 12.7% to $10.37 in pre-market trading after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.
- Chegg, Inc. (NYSE:CHGG) shares declined 12.1% to $6.30 in pre-market trading after the company posted first-quarter results and named Nathan Shultz as CEO.
- ADC Therapeutics SA (NASDAQ:ADCT) fell 6.7% to $4.20 in pre-market trading. The company, earlier during the month, announced the completion of dose escalation in LOTIS-7, a Phase 1b open-label clinical trial evaluating ZYNLONTA in combination with glofitamab or mosunetuzumab in heavily pre-treated patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
- Mesoblast Ltd (NASDAQ:MESO) shares declined 5.7% to $6.69 in pre-market trading.
- Coeur Mining, Inc. (NYSE:CDE) shares fell 5.7% to $4.63 in pre-market trading.
- Prudential plc (NYSE:PUK) slipped 5.1% to $17.84 in pre-market trading. Prudential, last month, reported worse-than-expected FY 2023 revenues and earnings.
- Yum China Holdings, Inc. (NYSE:YUMC) shares declined 5.1% to $38.00 in pre-market trading. Yum China posted upbeat earnings for its first quarter, while sales missed expectations.
- Sibanye Stillwater Limited (NYSE:SBSW) shares fell 5% to $4.82 in pre-market trading.
- Rambus Inc. (NASDAQ:RMBS) shares declined 4.1% to $58.01 in pre-market trading following first-quarter results.
- Coursera, Inc.（紐約證券交易所代碼：COUR）股價在盤前交易中下跌12.7％，至10.37美元，此前該公司公佈的第一季度財務業績喜憂參半，發佈的24財年收入指引低於預期。
- Chegg, Inc.（紐約證券交易所代碼：CHGG）股價在盤前交易中下跌12.1％，至6.30美元，此前該公司公佈了第一季度業績並任命內森·舒爾茨爲首席執行官。
- ADC Therapeutics SA（納斯達克股票代碼：ADCT）在盤前交易中下跌6.7％，至4.20美元。該公司在本月早些時候宣佈，LOTIS-7 的劑量遞增已完成，這是一項1b期開放標籤臨床試驗，評估ZYNLONTA與glofitamab或mosunetuzumab聯合治療的復發/難治性B細胞非霍奇金淋巴瘤患者。
- Mesoblast Ltd（納斯達克股票代碼：MESO）股價在盤前交易中下跌5.7％，至6.69美元。
- 科爾礦業公司（紐約證券交易所代碼：CDE）股價在盤前交易中下跌5.7％，至4.63美元。
- 保誠集團（紐約證券交易所代碼：PUK）在盤前交易中下跌5.1％，至17.84美元。保誠上個月公佈的2023財年收入和收益低於預期。
- 百勝中國控股有限公司（紐約證券交易所代碼：YUMC）股價在盤前交易中下跌5.1％，至38.00美元。百勝中國公佈了樂觀的第一季度收益，而銷售額未達到預期。
- Sibanye Stillwater Limited（紐約證券交易所代碼：SBSW）股價在盤前交易中下跌5％，至4.82美元。
- 第一季度業績公佈後，蘭布斯公司（納斯達克股票代碼：RMBS）股價在盤前交易中下跌4.1％，至58.01美元。
Now Read This: Investor Sentiment Improves Further, Dow Jumps Over 100 Points
立即閱讀這篇文章：投資者情緒進一步改善，道瓊斯指數上漲超過100點
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
譯文內容由第三人軟體翻譯。